The original success of Sildenafil undeniably reshaped the medication landscape, but betting in companies strongly reliant on generic versions presents a complex picture. Although early profits were significant, the cessation of patents and the emergence of less expensive alternatives have diminished market share. Therefore, a thorough assessment o